-
A288395-10mgHighly potent and competitive NPRA antagonist
-
A288395-1mgHighly potent and competitive NPRA antagonist
-
A288395-25mgHighly potent and competitive NPRA antagonist
-
A288395-5mgHighly potent and competitive NPRA antagonist
-
A288690-1mgAP 811 is a selective atrial natriuretic peptide clearance receptor (ANP-CR, NPR3) antagonist with a Ki of 0.48 nM. AP 811 displays >20000-fold selectivity for NPR3 over NPR1. AP 811 abolishes ANP-induced pump stimulation.
-
B288747-100mgSelective α4β1(VLA-4) inhibitor
-
B288747-10mgSelective α4β1(VLA-4) inhibitor
-
B288747-1mgSelective α4β1(VLA-4) inhibitor
-
B288747-25mgSelective α4β1(VLA-4) inhibitor
-
B288747-50mgSelective α4β1(VLA-4) inhibitor
-
B288747-5mgSelective α4β1(VLA-4) inhibitor
-
M287814-1mgSelective inhibitor of myosin light chain kinase